Johan Styrke

Kontakt

johan.styrke@umu.se

Verksam som

Adjungerad universitetslektor vid Institutionen för diagnostik och intervention

5A, Målpunkt H62, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: an open randomised controlled multicentre drug trial

Journal of Clinical Urology

Andreasson, Anders; Hällgren, Anita; Georgeoulas, Petros; et al.

Development of point-of-care tests for urinary bladder cancer: an historic review and view to future prospectives

Urologic Oncology, Elsevier 2025, Vol. 43, (7) : 401-411

Ecke, Thorsten H.; Styrke, Johan; Jagarlamudi, Kiran; et al.

Patient- and procedure-specific risk factors for urinary incontinence after robot-assisted radical prostatectomy: a nationwide, population-based study

European Urology Oncology, Elsevier 2025, Vol. 8, (4) : 932-940

Koss Modig, Katarina; Arnsrud Godtman, Rebecka; Carlsson, Stefan; et al.

Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

Scandinavian journal of urology, MJS Publishing 2025, Vol. 60 : 50-58

Orrason, Andri Wilberg; Scilipoti, Pietro; Garmo, Hans; et al.

Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer

Urologic Oncology

Szarvas, Tibor; Kramer, Gero; Jagarlamudi, Kiran; et al.

A novel approach to integrated prostate cancer diagnostics: insights from MRI, prostate biopsy, and pathology reports in a pilot study

BJU International, John Wiley & Sons 2025, Vol. 135, (2) : 245-248

Thimansson, Erik; Axén, Elin; Jäderling, Fredrik; et al.

Safety and efficacy in sclerotherapy of testicular hydro/spermatocele with 25 versus 50 mL Ethanol 99.5%; a randomised controlled phase II study

Scandinavian journal of urology, MJS Publishing 2025, Vol. 60 : 180-185

Velander, Sarah; Lundström, Karl-Johan; Styrke, Johan

Radical treatment for prostate cancer in men with limited life expectancy in Sweden

JAMA Network Open, American Medical Association (AMA) 2025, Vol. 8, (5)

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; et al.

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic: population-based study

Scandinavian journal of urology, Medical Journals Sweden 2025, Vol. 60 : 93-96

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; et al.

Clinical research nurses perceive their role as being like the hub of a wheel without real power: Empirical qualitative research

Nursing Open, John Wiley & Sons 2024, Vol. 11, (5)

Backman Lönn, Beatrice; Hörnsten, Åsa; Styrke, Johan; et al.

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

BJU International, John Wiley & Sons 2024, Vol. 134, (1) : 96-102

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; et al.

Natural history of nonmetastatic prostate cancer managed with watchful waiting

JAMA Network Open, American Medical Association (AMA) 2024, Vol. 7, (6)

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; et al.

Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry vs. data from a detailed research database

Translational Andrology and Urology, AME Publishing Company 2024, Vol. 13, (12) : 2757-2770

Wedholm, Albin; Wiberg, Erik; Styrke, Johan; et al.

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 93-100

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; et al.

Use of antiepileptic drugs and risk of prostate cancer: a nationwide case-control study in prostate cancer data base Sweden

Journal of Oncology, Hindawi Publishing Corporation 2023, Vol. 2023

George, Gincy; Garmo, Hans; Adolfsson, Jan; et al.

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

BJU International, John Wiley & Sons 2023, Vol. 131, (4) : 486-493

Orrason, Andri Wilberg; Styrke, Johan; Garmo, Hans; et al.

Frequency of biopsy and tumor grade before vs after introduction of prostate magnetic resonance imaging

JAMA Network Open, American Medical Association (AMA) 2023, Vol. 6, (8)

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; et al.

The risk of thromboembolism in patients with muscle invasive bladder cancer before and after cystectomy depending on blood group and neoadjuvant chemotherapy: a multicentre retrospective cohort study

Journal of Personalized Medicine, MDPI 2023, Vol. 13, (9)

Schulz Hägersten, Emma; Ottosson, Kristoffer; Pelander, Sofia; et al.

A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 20-26

Asad, Danna; Styrke, Johan; Hagsheno, Mohammad; et al.

Clarifying the role of clinical research nurses working in Sweden, using the clinical trial nursing questionnaire: swedish version

Nursing Open, John Wiley & Sons 2022, Vol. 9, (5) : 2434-2443

Backman Lönn, Beatrice; Hajdarevic, Senada; Olofsson, Niclas; et al.

Transitioning to the clinical research nurse role: a qualitative descriptive study

Journal of Advanced Nursing, John Wiley & Sons 2022, Vol. 78, (11) : 3817-3829

Backman Lönn, Beatrice; Hörnsten, Åsa; Styrke, Johan; et al.

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Acta Oncologica, Taylor & Francis 2022, Vol. 61, (3) : 328-332

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; et al.

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (2) : 104-111

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; et al.

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

International Journal of Cancer, John Wiley & Sons 2022, Vol. 151, (11) : 1925-1934

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; et al.

Community-onset urosepsis: incidence and risk factors for 30-day mortality – a retrospective cohort study

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 414-420

Holmbom, Martin; Andersson, Maria; Grabe, Magnus; et al.

Nomograms including UBC^® Rapid Test to detect primary bladder cancer based on a multicenter data set

BJU International, John Wiley & Sons 2022, Vol. 130, (6) : 754-763

Meisl, Christina J.; Karakiewicz, Pierre I.; Einarsson, Roland; et al.

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

PLOS ONE, Public library of science 2022, Vol. 17, (11)

Orrason, Andri Wilberg; Westerberg, Marcus; Albertsen, Peter; et al.

A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

European Urology, Elsevier 2022, Vol. 81, (3) : 285-293

Welén, Karin; Rosendal, Ebba; Gisslén, Magnus; et al.

IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines

European Urology, Elsevier 2021, Vol. 79, (2) : 173-173

Cornford, Philip; Smith, Emma Jane; MacLennan, Steven; et al.

Timing of the pubertal growth spurt and prostate cancer

Cancers, MDPI 2021, Vol. 13, (24)

Célind, Jimmy; Bygdell, Maria; Martikainen, Jari; et al.

Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden.

Acta Oncologica, Taylor & Francis 2021, Vol. 60, (1) : 56-60

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; et al.

Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (3) : 184-191

Fallara, Giuseppe; Sandin, Fredrik; Styrke, Johan; et al.

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic

PLOS ONE, Public Library of Science 2021, Vol. 16, (10)

Gedeborg, Rolf; Styrke, Johan; Loeb, Stacy; et al.

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Acta Oncologica, Taylor & Francis Group 2021, Vol. 60, (4) : 459-465

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; et al.

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

American Journal of Men's Health, Sage Publications 2021, Vol. 15, (6)

Hermann, Maria; Vikman, Hanna; Stattin, Pär; et al.

Patients' perspective on prostatic artery embolization: A qualitative study

SAGE Open Medicine, SAGE Open 2021, Vol. 9 : 1-6

Holm, Alexander; Lindgren, Hans; Blackberg, Mats; et al.

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm: nationwide, population-based cohort study

Scandinavian journal of urology, Taylor & Francis Group 2021, Vol. 55, (3) : 221-226

Lundström, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; et al.

Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status

Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (6) : 455-460

Tenninge, S.; Mogos, H.; Eriksson, E.; et al.

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Trials, BioMed Central 2021, Vol. 22, (1)

Welén, Karin; Överby, Anna K.; Ahlm, Clas; et al.

Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study

American Journal of Epidemiology, Oxford University Press 2021, Vol. 190, (10) : 2053-2063

Wilberg Orrason, Andri; Garmo, Hans; Styrke, Johan; et al.

Observational study on time on treatment with abiraterone and enzalutamide

PLOS ONE, Public Library of Science 2020, Vol. 15, (12)

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; et al.

Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single centre retrospective prognostic study

Translational Andrology and Urology, AME Publishing Company 2020, Vol. 9, (3) : 1062-1072

Mogos, Haben; Eriksson, Elisabeth K; Styrke, Johan; et al.

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Frontiers in Oncology, Frontiers Media S.A. 2020, Vol. 10

Parker, Jonathan; Crawley, Danielle; Garmo, Hans; et al.

Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden

F1000 Research, F1000 Research Ltd 2020, Vol. 9

Styrke, Johan; Resare, Sven; Lundström, Karl-Johan; et al.

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Frontiers in Medicine, Frontiers Media S.A. 2019, Vol. 6

Cazzaniga, Walter; Ventimiglia, Eugenio; Alfano, Massimo; et al.

Occurrence of abdominal bulging and hernia after open partial nephrectomy: a retrospective cohort study

Scandinavian journal of urology, Taylor & Francis 2018, Vol. 52, (1) : 54-58

Inkiläinen, Aapo; Styrke, Johan; Ljungberg, Börje; et al.

Evaluation of the diagnostic accuracy of UBC(®) Rapid in bladder cancer: a Swedish multicentre study

Scandinavian journal of urology, Vol. 51, (4) : 293-300

Styrke, Johan; Henriksson, Helene; Ljungberg, Börje; et al.

Symptoms, disability, and life satisfaction five years after whiplash injuries

Scandinavian Journal of Pain, Elsevier 2014 : 229-236

Styrke, Johan; Sojka, Peter; Björnstig, Ulf; et al.

Neck injury after whiplash trauma in a defined population in Northern Sweden: long term sick leave and costs of low productivity

Epidemiology: Open Access, Vol. 4, (4)

Styrke, Johan; Stålnacke, Britt-Marie; Bylund, Per-Olof; et al.

Sex-differences in symptoms, disability, and life satisfaction three years after mild traumatic brain injury: a population-based cohort study

Journal of Rehabilitation Medicine, Stiftelsen Rehabiliteringsinformation 2013, Vol. 45, (8) : 749-757

Styrke, Johan; Sojka, Peter; Björnstig, Ulf; et al.

Visa publikationer i DiVA

Forskningsprojekt

1 juni 2025

Kapillär hemprovtagning av PSA inom ramen för organiserad prostatacancertestning

1 januari 2018

Testiscancer

1 januari 2018

Urinblåsecancer